You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

 

Online download statistics by month:

Online download statistics by month: February 2021 to February 2026

AbstractFullPdf
Feb 202111581158546
Mar 2021931930394
Apr 2021592592255
May 2021589589223
Jun 2021448448183
Jul 2021361361135
Aug 2021377377129
Sep 2021413413189
Oct 2021413413187
Nov 2021513513216
Dec 2021506511179
Jan 2022621656258
Feb 2022336358181
Mar 2022426450199
Apr 2022399438193
May 2022404437237
Jun 2022321333156
Jul 2022308329193
Aug 2022291310158
Sep 2022275301200
Oct 2022290307183
Nov 2022280288177
Dec 2022249249134
Jan 2023244248131
Feb 2023306309146
Mar 2023337340184
Apr 2023273276153
May 2023246250134
Jun 2023280283110
Jul 2023313321159
Aug 2023272275180
Sep 2023252254140
Oct 2023270274150
Nov 2023314316167
Dec 2023286293188
Jan 2024236238160
Feb 2024214215149
Mar 2024300307238
Apr 2024382386203
May 2024295299169
Jun 2024292293157
Jul 2024266269161
Aug 2024227226142
Sep 2024295297599
Oct 2024339340257
Nov 2024333339284
Dec 2024342347233
Jan 2025367368222
Feb 2025508510309
Mar 2025371373273
Apr 2025419421242
May 2025360361224
Jun 2025213214128
Jul 2025110
Oct 2025110
Feb 2026110
Total196562000610897